Perhaps one of the more surprising AI value plays is Google parent Alphabet ( GOOGL -0.01%) ( GOOG 0.06%). Alphabet has ...

AI is a new tool to help investors analyze data, but can it beat the stock market? Here's how a chatbot's stock picks fared ...

Discussing how the market initially reacted, Cramer explained that when the panel of federal judges declared the majority of ...

You can find investment watches through a variety of channels. "For brand-new watches, authorized dealers are the safest ...

Have you ever read a headline that made you want to throw your phone across the room? Not out of anger, but frustration for your own bad investing decisions? You know the headlines I mean. “NVIDIA up ...

What are the best tech-focused ETFs for investors right now? Seeking Alpha analysts offer their picks. Read more here.

Salesforce lags despite solid profits, but AI traction, M&A moves, and low valuation offer upside. See why CRM stock is ...

Regeneron Pharmaceuticals (NasdaqGS:REGN) announced favorable Phase 3 trial results for itepekimab and entered a significant licensing agreement with Telesis Bio, enhancing its R&D capabilities.